The Fund aims provide a monthly income of 2% over base rate whilst keeping fluctuations in the unit price to a minimum.
Name | % Net Assets |
---|---|
BP | 2.8% |
Vodafone | 1.9% |
GlaxoSmithKline | 1.9% |
HSBC | 1.8% |
Royal Dutch Shell | 1.1% |
RBS | 1.1% |
AstraZeneca | 0.9% |
Barclays | 0.8% |
HBOS | 0.8% |
Lloyds TSB | 0.6% |
Key | % Net Assets |
---|---|
BP | 2.8% |
Vodafone | 1.9% |
GlaxoSmithKline | 1.9% |
HSBC | 1.8% |
Other | 91.6% |
Date | 20-May-2024 |
---|---|
Bid | 11.57p |
Offer | 12.14p |
Currency | GBP |
Change | 0.005p |
% | -0.04% |
YTD change | 0.14p |
YTD % | 1.15% |
Fund Inception | 26/01/1993 |
---|---|
Fund Manager | Chris Childs |
TER | 1.74 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | £2500 |
Additional | £500 |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | -0.10 |
You are here: research